WINDLAS
Windlas Biotech Limited
Pharmaceuticals
Share price
₹994
Market cap
₹2,102 Cr
1Y return
▼ 1%
A leading pharmaceutical contract development and manufacturing organization, Windlas Biotech specializes in producing solid and liquid dosage forms for domestic and international clients. The company provides comprehensive CDMO services including product discovery, development, and commercial manufacturing of generic and complex generic medications. Its vertically integrated operations, technical capabilities, and focus on quality manufacturing distinguish it within India's pharmaceutical sector.
Investors holding Windlas Biotech Limited
Latest move
Bandhan Mutual FundIncreased
Bandhan Mutual Fund increased its stake in Windlas Biotech Limited from 1.11% to 1.43% by buying 61,858 shares. The stake is worth ₹25.13 Cr based on the company's share price of ₹852.25.
Sign in to read more
Whales made 2 more moves in Windlas Biotech Limited
Sign in to see who is buying and selling.
Sign in to find out